SI
HSTO

Sofinnova Investments’s Histogen Inc. Common Stock HSTO Stock Holding History

Sofinnova Investments’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,191
Closed -$1.29M – 76
2018
Q4 		$1.1M Buy
3,191
+496
+18% +$385K 0.14% 56
2018
Q3 		$3.13M Sell
2,695
-1,599
-37% -$1.47M 0.28% 47
2018
Q2 		$3.68M Buy
+4,294
New +$3.57M 0.42% 40

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $58.9B AUM 51.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Sofinnova Investments's HSTO Position: Q1 2019 in Review

Sofinnova Investments sold out of Histogen Inc. Common Stock (HSTO) in Q1 2019, closing a stake of 3,191 shares — an estimated $1.29M sold.

Sofinnova Investments first reported a position in HSTO in Q2 2018 and held it in 3 quarters. The position peaked at $3.68M in Q2 2018. 42 funds tracked by Wall St. Rank hold HSTO as of Q1 2019.

  • Sofinnova Investments reported no remaining Histogen Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Sofinnova Investments sold 3,191 Histogen Inc. Common Stock shares in Q1 2019, an estimated $1.29M.
  • Sofinnova Investments first reported a position in Histogen Inc. Common Stock in Q2 2018 and held it in 3 quarters.
  • Sofinnova Investments's Histogen Inc. Common Stock position peaked at $3.68M in Q2 2018.
  • 42 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2019.

Based on Sofinnova Investments's 13F filing for Q1 2019, filed 15 May 2019.